Why the hype why the rushJim Cramer (earlier July recording) put it rather succinctly, Canopy’s sleep pharmaceuticals will likely “replace Ambien, Xanax, and Klonopin”. The total sleep aid market is valued at 50-75B$ annually on several google sites. With a hopper popping with an endless number of medicinal product ideas under consideration, beverages and other transformative products, business history will likely record this decision to be a huge win for CBrands while providingCanopy with the time advantage and financial clout to even further greatly distance itself from the rest of mj sector. Deep, long and strapped in for Bruce et al will take this once in a lifetime experience. Cheers
https://www.thestreet.com/video/jim-cramer-what-you-need-to-know-about-canopy-growths-stock-14649598